Dawn Of A New Era? Korean Biopharma M&A Landscape Set For Change

Cash-Rich Pharmas, Conglomerates Hunt For Growth Engines

 
• By Jung Won Shin
dawn
New Bioventures Seen More Open-Minded Toward M&As • Source: Alamy

More from South Korea

More from Focus On Asia